Completed PHASE2 INTERVENTIONAL 1-arm NCT04849351

Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma

A Multi-center, Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of HMPL-689 in Patients With Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma

Sponsor: Hutchison Medipharma Limited

Conditions Follicular Lymphoma Marginal Zone Lymphoma

Interventions HMPL-689

Updated 8 times since 2021 Last updated: Apr 3, 2025 Started: Apr 15, 2021 Primary completion: Feb 29, 2024 Completion: Feb 29, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Follicular Lymphoma and Marginal Zone Lymphoma, this trial is completed. The trial is conducted by Hutchison Medipharma Limited and has accumulated 8 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
May 2025 — Sep 2025 [monthly]

Completed PHASE2

Status: Unknown → Completed
Jan 2025 — May 2025 [monthly]

Unknown PHASE2

Status: Recruiting → Unknown
Sep 2024 — Jan 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Nov 2022 — Jul 2024 [monthly]

Recruiting PHASE2
Sep 2021 — Nov 2022 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
May 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hutchison Medipharma Limited

Data source: Hutchmed

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Binzhou, China , Changchun, China , Changsha, China , Chengde, China , Chengdu, China , Chongqing, China , Fuzhou, China , Gannan, China , Ganzhou, China and 31 more locations